FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kazuyuki Itoh

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Physiology

Co-author Network

Publications

TOP 3
Norifumi Naka; Satoshi Takenaka; Nobuhito Araki; Toshitada Miwa; Nobuyuki Hashimoto; Kiyoko Yoshioka; Susumu Joyama; Ken-Ichiro Hamada; Yoshitane Tsukamoto; Yasuhiko Tomita; Takafumi Ueda; Hideki Yoshikawa; Kazuyuki Itoh
Synovial sarcoma is a stem cell malignancy.
Satoshi Takenaka; Norifumi Naka; Nobuhito Araki; Nobuyuki Hashimoto; Takafumi Ueda; Kiyoko Yoshioka; Hideki Yoshikawa; Kazuyuki Itoh
Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
Hideki Yoshikawa; Kiyoko Yoshioka; Takanobu Nakase; Kazuyuki Itoh
Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kazuyuki Itoh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Norifumi Naka; Satoshi Takenaka; Nobuhito Araki; Toshitada Miwa; Nobuyuki Hashimoto; Kiyoko Yoshioka; Susumu Joyama; Ken-Ichiro Hamada; Yoshitane Tsukamoto; Yasuhiko Tomita; Takafumi Ueda; Hideki Yoshikawa; Kazuyuki Itoh
Synovial sarcoma is a stem cell malignancy.
Stem cells (Dayton, Ohio) 2010;28(7):1119-31.
2010: Satoshi Takenaka; Norifumi Naka; Nobuhito Araki; Nobuyuki Hashimoto; Takafumi Ueda; Kiyoko Yoshioka; Hideki Yoshikawa; Kazuyuki Itoh
Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
International journal of oncology 2010;36(4):823-31.
2009: Hideki Yoshikawa; Kiyoko Yoshioka; Takanobu Nakase; Kazuyuki Itoh
Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study.
Clinical orthopaedics and related research 2009;467(12):3087-95.
2008: Manando Nakasaki; Kiyoko Yoshioka; Yasuhide Miyamoto; Takehiko Sasaki; Hideki Yoshikawa; Kazuyuki Itoh
IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts.
Bone 2008;43(5):869-79.
2008: Miyako Baba; Masahiro Inoue; Kazuyuki Itoh; Yasuko Nishizawa
Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
Biochemical and biophysical research communications 2008;374(1):111-6.
2007: Yuji Fukushima; Masakazu Tamura; Hidemitsu Nakagawa; Kazuyuki Itoh
Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid.
Journal of neurosurgery 2007;107(3):578-85.
2006: Susumu Joyama; Norifumi Naka; Yoshitane Tsukamoto; Hideki Yoshikawa; Kazuyuki Itoh
Dendritic cell immunotherapy is effective for lung metastasis from murine osteosarcoma.
Clinical orthopaedics and related research 2006;453():318-27.
2006: Tsukasa Sotobori; Takafumi Ueda; Akira Myoui; Kiyoko Yoshioka; Manando Nakasaki; Hideki Yoshikawa; Kazuyuki Itoh
Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts.
Experimental cell research 2006;312(19):3927-38.
2005: Norifumi Naka; Susumu Joyama; Yoshitane Tsukamoto; Kiyoko Yoshioka; Nobuyuki Hashimoto; Takeshi Ujiiye; Tsukasa Hayashi; Masako Kawase; Masayuki Mano; Shingo Ishiguro; Akira Myoui; Takafumi Ueda; Hideki Yoshikawa; Nobuhito Araki; Kazuyuki Itoh
Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.
The Journal of molecular diagnostics : JMD 2005;7(2):187-97.
2004: Hirofumi Nakanishi; Kiyoko Yoshioka; Susumu Joyama; Nobuhito Araki; Akira Myoui; Shingo Ishiguro; Takafumi Ueda; Hideki Yoshikawa; Kazuyuki Itoh
Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
The American journal of pathology 2004;165(2):471-80.
2004: Hirofumi Nakanishi; Nobuhito Araki; Susumu Joyama; Chikahisa Higuchi; Masayuki Mano; Shingo Ishiguro; Kazuyuki Itoh; Takafumi Ueda; Hideki Yoshikawa
Myxoid liposarcoma with adipocytic maturation: detection of TLS/CHOP fusion gene transcript.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2004;13(2):92-6.
2003: Kiyoko Yoshioka; Victoria Foletta; Ora Bernard; Kazuyuki Itoh
A role for LIM kinase in cancer invasion.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7247-52.
2002: Kohji Kuriyama; Chikahisa Higuchi; Keiichi Tanaka; Hideki Yoshikawa; Kazuyuki Itoh
A novel anti-rheumatic drug, T-614, stimulates osteoblastic differentiation in vitro and bone morphogenetic protein-2-induced bone formation in vivo.
Biochemical and biophysical research communications 2002;299(5):903-9.
2002: Chikahisa Higuchi; Akira Myoui; Nobuyuki Hashimoto; Kohji Kuriyama; Kiyoko Yoshioka; Hideki Yoshikawa; Kazuyuki Itoh
Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(10):1785-94.